• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威尔姆斯瘤基因WT1在食管癌中的过表达。

Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.

作者信息

Oji Yusuke, Yano Masahiko, Nakano Yoko, Abeno Sakie, Nakatsuka Shin-Ichi, Ikeba Ai, Yasuda Takushi, Fujiwara Yoshiyuki, Takiguchi Shuji, Yamamoto Hirofumi, Fujita Seiichiro, Kanato Keisuke, Ito Ken, Jomgeow Tanyarat, Kawakami Manabu, Tsuboi Akihiro, Shirakata Toshiaki, Nishida Sumiyuki, Hosen Naoki, Oka Yoshihiro, Aozasa Katsuyuki, Monden Morito, Sugiyama Haruo

机构信息

Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7, Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Anticancer Res. 2004 Sep-Oct;24(5B):3103-8.

PMID:15510596
Abstract

BACKGROUND

The Wilms' tumor gene WT1 is overexpressed in various kinds of solid cancers. However, it remains unclear whether WT1 is expressed in esophageal squamous cell carcinoma.

MATERIALS AND METHODS

Expression of the WT1 gene was examined by real-time RT-PCR in 12 esophageal squamous cell carcinoma (ESCC) and by immunohistochemistry in 9 of these 12 and another 29.

RESULTS

Real-time RT-PCR showed that the WT1 mRNA was overexpressed in all of the 12 ESCC examined Immunohistochemical analysis showed that the WT1 protein was overexpressed in ESCC cells in 36 (95%) of the 38 examined Furthermore, expression of the WT1 protein was examined in 20 esophageal squamous dysplasia. The WT1 protein was overexpressed in 5 (45%) out of 11 mild dysplasia and in 8 (89%) out of 9 moderate to severe dysplasia.

CONCLUSION

These results may indicate an important role of the WT1 gene in the tumorigenesis of ESCC.

摘要

背景

威尔姆斯瘤基因WT1在多种实体癌中过表达。然而,WT1在食管鳞状细胞癌中是否表达仍不清楚。

材料与方法

通过实时逆转录聚合酶链反应检测12例食管鳞状细胞癌中WT1基因的表达,并对其中9例以及另外29例进行免疫组织化学检测。

结果

实时逆转录聚合酶链反应显示,在检测的所有12例食管鳞状细胞癌中WT1信使核糖核酸均过表达。免疫组织化学分析显示,在检测的38例中,36例(95%)食管鳞状细胞癌细胞中WT1蛋白过表达。此外,对20例食管鳞状发育异常进行了WT1蛋白表达检测。在11例轻度发育异常中的5例(45%)以及9例中重度发育异常中的8例(89%)中WT1蛋白过表达。

结论

这些结果可能表明WT1基因在食管鳞状细胞癌的肿瘤发生中起重要作用。

相似文献

1
Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.威尔姆斯瘤基因WT1在食管癌中的过表达。
Anticancer Res. 2004 Sep-Oct;24(5B):3103-8.
2
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.利用人类癌症cDNA阵列分析食管鳞状细胞癌(ESCC)中差异表达的癌症相关基因:癌基因MET的过表达与ESCC中的肿瘤分化相关。
Clin Cancer Res. 2001 Nov;7(11):3519-25.
3
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.Fascin过表达在人食管鳞状细胞癌中的预后意义。
Clin Cancer Res. 2005 Apr 1;11(7):2597-605. doi: 10.1158/1078-0432.CCR-04-1378.
4
Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.类stomatin蛋白2在癌症中过表达,并参与调控人食管鳞状细胞癌中的细胞生长和细胞黏附。
Clin Cancer Res. 2006 Mar 1;12(5):1639-46. doi: 10.1158/1078-0432.CCR-05-1858.
5
DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.非癌性和癌性人类食管正常上皮及鳞状发育异常中的DNA倍体、P53表达和细胞增殖
Anticancer Res. 1996 Jan-Feb;16(1):201-8.
6
Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.组织微阵列分析显示,蛋白质表达模式与食管鳞状细胞癌的进展之间存在紧密关联。
BMC Cancer. 2006 Dec 22;6:296. doi: 10.1186/1471-2407-6-296.
7
Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.RhoA和RhoC基因表达在食管鳞状细胞癌中的临床及预后意义
Ann Surg Oncol. 2007 Dec;14(12):3593-601. doi: 10.1245/s10434-007-9562-x. Epub 2007 Sep 25.
8
SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.SnoN过表达预示食管鳞状细胞癌患者的生存预后较差。
Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y. Epub 2008 Jul 9.
9
[Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].[河南省食管癌高发区食管鳞状细胞癌及癌旁组织中膜联蛋白II表达失调]
Ai Zheng. 2007 Jul;26(7):730-6.
10
Loss of MAL expression in precancerous lesions of the esophagus.食管癌前病变中MAL表达缺失。
Ann Surg Oncol. 2007 May;14(5):1670-7. doi: 10.1245/s10434-006-9064-2. Epub 2006 Dec 6.

引用本文的文献

1
Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms.WT1 在乳腺癌所有分子亚型中的过表达及其对生存的影响:探究不同 WT1 亚型的致癌和肿瘤抑制作用。
Mol Biol Rep. 2024 Apr 20;51(1):544. doi: 10.1007/s11033-024-09450-4.
2
A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy.一项评价 WT1 肽负载树突状细胞疫苗(TLP0-001)联合替吉奥治疗晚期胰腺癌的双盲随机对照临床研究 **提示**:我给出的译文,仅为示意,具体翻译结果可能因专业领域或上下文而有所不同。
Trials. 2019 Apr 27;20(1):242. doi: 10.1186/s13063-019-3332-5.
3
Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.WT1肽脉冲树突状细胞联合多西他赛用于食管癌疫苗接种的初步研究。
Oncol Lett. 2018 Jul;16(1):1348-1356. doi: 10.3892/ol.2018.8734. Epub 2018 May 17.
4
Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.WT1 第一个锌指在 DNA 序列特异性中的作用:与 Denys-Drash 综合征相关的 WT1 突变体在 ZF1 中增强了对一组 WT1 结合位点的亲和力。
Nucleic Acids Res. 2018 May 4;46(8):3864-3877. doi: 10.1093/nar/gkx1274.
5
Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.非裔美国人中与巴雷特食管和食管腺癌易感性相关的基因组区域:BETRNet交叉混合研究
PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.
6
Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.与Denys-Drash综合征相关的WT1谷氨酰胺369突变体具有改变的序列偏好和对表观遗传修饰的改变反应。
Nucleic Acids Res. 2016 Dec 1;44(21):10165-10176. doi: 10.1093/nar/gkw766. Epub 2016 Sep 4.
7
Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.靶向WT1的微小RNA-125a缺乏会导致髓系恶性肿瘤和泌尿生殖系统异常。
Oncogene. 2016 Feb 25;35(8):1003-14. doi: 10.1038/onc.2015.154. Epub 2015 May 11.
8
Functional human Th17 clones with WT1-specific helper activity.具有 WT1 特异性辅助活性的功能性人 Th17 克隆。
Cancer Immunol Immunother. 2013 Apr;62(4):801-10. doi: 10.1007/s00262-012-1385-3. Epub 2012 Dec 29.
9
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.针对血液系统恶性肿瘤和实体瘤患者的 Wilms 瘤蛋白 1(WT1)的主动特异性免疫治疗:来自早期临床试验的经验。
Oncologist. 2012;17(2):250-9. doi: 10.1634/theoncologist.2011-0240. Epub 2012 Jan 30.
10
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.实体瘤患者和健康供者中针对 Wilms' 瘤基因(WT1)的 CD8+ T 细胞的 T 细胞受体 β 链可变区基因的偏倚性使用。
Cancer Sci. 2012 Mar;103(3):408-14. doi: 10.1111/j.1349-7006.2011.02163.x. Epub 2012 Jan 17.